Dr. Yan joined our Board of Directors in 2023. He has over 30 years of experience in drug research and development, manufacturing, and management, including more than 15 years working with pharmaceutical companies and contract research organizations. Since 2020, Dr. Yan has served as an executive vice president and head of R&D and manufacturing at Gloria Biosciences Co. Ltd. From 2014 to 2019, Dr. Yan served as the senior director and senior research fellow of the oncology and immunology business unit at WuXi AppTec (Shanghai) Co., Ltd. (SHA: 603259). Prior to these roles, Dr. Yan held positions at various academic institutions, including senior research scientist in the department of thoracic and cardio surgery, and the pharmaceutical development center, at the University of Texas’s MD Anderson Cancer Center (2006 to 2013); visiting scholar and research scientist on the pharmaceutical sciences faculty at Kyushu University (2001 to 2002); deputy director in the institute of medical raw materials at Tianjin Pharmaceutical Group Corp; and director and co-founder of the Shenyang Huiming Institute of Chinese Traditional Medicine (1995 to 1998). Dr. Yan received his Ph.D in pharmaceutical science, and his M.Sc. in pharmaceutics, from Shenyang Pharmaceutical University.He received his B.Sc. from Jilin University in polymer chemistry. Dr. Yan completed his postdoctoral training in the field of pharmacology and biochemistry in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine (2003 to 2006).